Advancing surgical outcomes through cardiovascular biomarker sub-phenotyping.
Where this comes from
- Record sourced from PubMed, PMID 40089402.
- Also identified by DOI 10.1016/j.bja.2025.02.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent findings from Gutierrez del Arroyo and colleagues identified distinct sub-phenotypes in patients undergoing major noncardiac surgery based on biomarkers such as N terminal pro-brain natriuretic peptide, renin, aldosterone, and angiotensin-converting enzyme 2, which were associated with varying risks of postoperative myocardial injury. Although their findings highlight the potential of sub-phenotyping for advancing perioperative precision medicine, further research is needed to validate these sub-phenotypes and explore their role in tailoring perioperative management strategies.
Medical subject headings
- Humans
- Biomarkers
- Biomarkers/blood
- Postoperative Complications
- Postoperative Complications/blood
- Phenotype
- Cardiovascular Diseases
- Cardiovascular Diseases/diagnosis
- Cardiovascular Diseases/blood
- Precision Medicine
- Precision Medicine/methods